Health3 sources
MPs criticize slow NHS rollout of weight-loss drug Mounjaro
- Only about 6% of eligible patients will receive Mounjaro through the NHS in the first three years.
- MPs describe the current rollout plans as 'unambitious' and 'woefully small'.
- The rollout is creating concerns of a 'two-tier system' in healthcare.
- MPs urge for an 'urgent' boost in the rollout of Mounjaro.
- The current plans aim to provide Mounjaro to 6% of eligible patients by 2028.